Medpace Holdings Inc (MEDP)
$345.93 -$2.66 (-0.77%) 10:54 PM 12/14/24
NASDAQ | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$10.75B -
Day's Range
$340.06 - $351.50 -
Volume
232,175 -
52 Week Low / High
$277.72 - $459.77 -
PE Ratio
30.29x -
PEG Ratio
1.65 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 4
- Strong Buy
- 0
- Buy
- 6
- Hold
- 1
- Sell
- 0
- Strong Sell
- $269.50
- Target Price
Company News
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Medpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024 — Sep 24th, 2024
CINCINNATI, September 24, 2024--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its third quarter 2024 financial results after the market close on Monday, October 21, 2024. The Company will host a conference call the following morning,...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Medpace Holdings, Inc. (MEDP): A Bull Case Theory — Sep 24th, 2024
We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on The LongView’s Substack by Matas Baliukonis. In this article, we will summarize the bulls’ thesis on MEDP. MEDP Technologies, Inc. share was trading at $361.95 as of Sept 23rd. MEDP’s trailing and forward P/E were 3...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3 — Oct 16th, 2024
LVS Advisory, a New York City-based full-service investment firm, recently released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong Q3 and appreciated nearly 5% in the first nine months. Despite a challenging...
-
Here’s Why Medpace (MEDP) Detracted in Q3 — Oct 10th, 2024
Headwaters Capital Management, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.0% (+8.8% net) in the third quarter compared to a 9.2% return for the Russell Mid Cap Index. Interest rate redu...
-
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention? — Oct 17th, 2024
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will u...
Portfolio
Comprised of 1 portfolios